{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:17:24Z","timestamp":1757618244057,"version":"3.44.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC 82200177","NSFC 82300244","NSFC 82470127","NSFC 82400264","NSFC 82100229","NSFC 82170218, 82470221"],"award-info":[{"award-number":["NSFC 82200177","NSFC 82300244","NSFC 82470127","NSFC 82400264","NSFC 82100229","NSFC 82170218, 82470221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Suzhou Projects","award":["2023QN07","DZXYJ202305, GSWS2023048, 2020ZKPB02"],"award-info":[{"award-number":["2023QN07","DZXYJ202305, GSWS2023048, 2020ZKPB02"]}]},{"name":"The National Key Research and Development Program of China","award":["2022YFC2502700"],"award-info":[{"award-number":["2022YFC2502700"]}]},{"name":"the Suzhou Municipal Key Laboratory","award":["SZS201615, SKY2022012, SZS2023014"],"award-info":[{"award-number":["SZS201615, SKY2022012, SZS2023014"]}]},{"name":"Soochow University of Medical School","award":["ML13101223"],"award-info":[{"award-number":["ML13101223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00277-025-06461-4","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:12:52Z","timestamp":1750309972000},"page":"3153-3163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of rabbit ATLG and ATG in allogeneic hematopoietic stem cell transplantation for children with acquired severe aplastic anemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Senlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengqin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"17","key":"6461_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS (2018) Aplastic anemia. N Engl J Med 379(17):1643\u20131656","journal-title":"N Engl J Med"},{"issue":"1","key":"6461_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13045-021-01159-2","volume":"14","author":"XH Zhang","year":"2021","unstructured":"Zhang XH et al (2021) The consensus from the Chinese society of hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. J Hematol Oncol 14(1):145","journal-title":"J Hematol Oncol"},{"issue":"4","key":"6461_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjh.13614","volume":"171","author":"C Dufour","year":"2015","unstructured":"Dufour C et al (2015) Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK paediatric BMT working party, paediatric diseases working party and severe aplastic anaemia working party of EBMT. Br J Haematol 171(4):585\u2013594","journal-title":"Br J Haematol"},{"issue":"29","key":"6461_CR4","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1200\/JCO.20.00150","volume":"38","author":"YJ Chang","year":"2020","unstructured":"Chang YJ et al (2020) Antithymocyte Globulin for matched sibling donor transplantation in patients with hematologic malignancies: A multicenter, Open-Label, randomized controlled study. J Clin Oncol 38(29):3367\u20133376","journal-title":"J Clin Oncol"},{"issue":"7","key":"6461_CR5","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41409-018-0393-0","volume":"54","author":"A Kumar","year":"2019","unstructured":"Kumar A et al (2019) Antithymocyte Globulin for graft-versus-host disease prophylaxis: an updated systematic review and meta-analysis. Bone Marrow Transpl 54(7):1094\u20131106","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"6461_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41409-020-0792-x","volume":"55","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F et al (2020) Rabbit ATG\/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel. Bone Marrow Transpl 55(6):1093\u20131102","journal-title":"Bone Marrow Transpl"},{"key":"6461_CR7","doi-asserted-by":"crossref","unstructured":"Liu L et al (2021) Comparison of 2 different rabbit anti-thymocyte globulin (r-ATG) preparations: thymocyte r-ATG versus T lymphoblast cell line r-ATG in allogeneic hematopoietic stem cell transplantation for acquired severe aplastic anemia: propensity score-matched analysis. Transplant Cell Ther 27(2):186.e1-186.e3","DOI":"10.1016\/j.bbmt.2020.08.020"},{"issue":"6","key":"6461_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s00277-020-04014-5","volume":"99","author":"L Zhou","year":"2020","unstructured":"Zhou L, Gao ZY, Lu DP (2020) Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience. Ann Hematol 99(6):1389\u20131400","journal-title":"Ann Hematol"},{"issue":"5","key":"6461_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00277-024-05724-w","volume":"103","author":"Z Tian","year":"2024","unstructured":"Tian Z et al (2024) Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation. Ann Hematol 103(5):1729\u20131736","journal-title":"Ann Hematol"},{"issue":"10","key":"6461_CR10","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41409-020-0874-9","volume":"55","author":"L Liu","year":"2020","unstructured":"Liu L et al (2020) Combination of haploidentical Haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases. Bone Marrow Transpl 55(10):2017\u20132025","journal-title":"Bone Marrow Transpl"},{"key":"6461_CR11","doi-asserted-by":"publisher","first-page":"204062072211344","DOI":"10.1177\/20406207221134409","volume":"13","author":"D Yao","year":"2022","unstructured":"Yao D et al (2022) Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-versus-host disease in pediatric patients with acquired severe aplastic anemia. Ther Adv Hematol 13:20406207221134409","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"6461_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"LP Xu","year":"2017","unstructured":"Xu LP et al (2017) Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol 10(1):25","journal-title":"J Hematol Oncol"},{"issue":"4","key":"6461_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jpurol.2009.02.199","volume":"5","author":"DB Decker","year":"2009","unstructured":"Decker DB, Karam JA, Wilcox DT (2009) Pediatric hemorrhagic cystitis. J Pediatr Urol 5(4):254\u2013264","journal-title":"J Pediatr Urol"},{"issue":"4","key":"6461_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H et al (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295\u2013304","journal-title":"Transplantation"},{"issue":"3","key":"6461_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH et al (2015) National institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-Host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transpl 21(3):389\u2013401e1","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"6461_CR16","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387\u20131394","journal-title":"Leukemia"},{"issue":"2","key":"6461_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/10428194.2015.1045901","volume":"57","author":"W Huang","year":"2016","unstructured":"Huang W et al (2016) The efficacy and safety of rabbit anti-thymocyte Globulin vs rabbit anti-T-lymphocyte Globulin in peripheral blood stem cell transplantation from unrelated donors. Leuk Lymphoma 57(2):355\u2013363","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"6461_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00277-023-05220-7","volume":"102","author":"L Wang","year":"2023","unstructured":"Wang L et al (2023) Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Ann Hematol 102(6):1569\u20131579","journal-title":"Ann Hematol"},{"key":"6461_CR19","doi-asserted-by":"crossref","unstructured":"Zhang H et al (2025) Comparison of ATG-thymoglobulin with atg-fresenius in patients with hematological malignancies who undergo allogeneic hematopoietic stem cell transplantation: a propensity score-matched analysis. Ann Hematol 104(3):1907\u20131916","DOI":"10.1007\/s00277-025-06267-4"},{"issue":"3","key":"6461_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1179\/102453309X12583347113852","volume":"15","author":"K Terasako","year":"2010","unstructured":"Terasako K et al (2010) The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. Hematology 15(3):165\u2013169","journal-title":"Hematology"},{"key":"6461_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.trim.2017.09.002","volume":"45","author":"J Bamoulid","year":"2017","unstructured":"Bamoulid J et al (2017) Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins. Transpl Immunol 45:48\u201352","journal-title":"Transpl Immunol"},{"key":"6461_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2017.10.019","volume":"148","author":"S Chou","year":"2017","unstructured":"Chou S (2017) A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance. Antiviral Res 148:1\u20134","journal-title":"Antiviral Res"},{"issue":"2","key":"6461_CR23","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/S2352-3026(23)00344-7","volume":"11","author":"D Russo","year":"2024","unstructured":"Russo D et al (2024) Efficacy and safety of extended duration letermovir prophylaxis in recipients of Haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Haematol 11(2):e127\u2013e135","journal-title":"Lancet Haematol"},{"issue":"11","key":"6461_CR24","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00277-021-04642-5","volume":"100","author":"Y Ding","year":"2021","unstructured":"Ding Y et al (2021) Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes: EBV and CMV reactivation post allo-HCT in NHL. Ann Hematol 100(11):2773\u20132785","journal-title":"Ann Hematol"},{"issue":"6 Suppl 12","key":"6461_CR25","first-page":"9","volume":"27","author":"AJ Grillo-L\u00f3pez","year":"2000","unstructured":"Grillo-L\u00f3pez AJ (2000) Rituximab: an insider\u2019s historical perspective. Semin Oncol 27(6 Suppl 12):9\u201316","journal-title":"Semin Oncol"},{"key":"6461_CR26","doi-asserted-by":"crossref","unstructured":"Patel C et al (2023) Pre-Hematopoietic stem cell transplantation rituximab for Epstein-Barr virus and Post-Lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transpl Cell Ther 29(2):132.e1-132.e5","DOI":"10.1016\/j.jtct.2022.10.023"},{"key":"6461_CR27","doi-asserted-by":"publisher","first-page":"1427637","DOI":"10.3389\/fimmu.2024.1427637","volume":"15","author":"A Marja\u0144ska","year":"2024","unstructured":"Marja\u0144ska A et al (2024) Impact of prophylaxis with rituximab on EBV-related complications after allogeneic hematopoietic cell transplantation in children. Front Immunol 15:1427637","journal-title":"Front Immunol"},{"issue":"20","key":"6461_CR28","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O et al (2009) Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 113(20):4992\u20135001","journal-title":"Blood"},{"issue":"11","key":"6461_CR29","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1080\/10428194.2018.1439584","volume":"59","author":"N Polverelli","year":"2018","unstructured":"Polverelli N et al (2018) Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years. Leuk Lymphoma 59(11):2700\u20132705","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"6461_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bmt.1703640","volume":"30","author":"R Pihusch","year":"2002","unstructured":"Pihusch R et al (2002) The impact of antithymocyte Globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transpl 30(6):347\u2013354","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"6461_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s12032-014-0465-y","volume":"32","author":"W Huang","year":"2015","unstructured":"Huang W et al (2015) Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte Globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study. Med Oncol 32(2):465","journal-title":"Med Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06461-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06461-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T20:30:43Z","timestamp":1757190643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06461-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["6461"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06461-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of the Children\u2019s Hospital of Soochow University and conducted according to the Declaration of Helsinki. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}